Target intelligence / Profile preview

RNA, U6 small nuclear 442, pseudogene (RNU6-442P)

Target
RNU6-442P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, U6 small nuclear 442, pseudogene (RNU6-442P), is a member of the U6 snRNA pseudogene family. U6 snRNAs are essential non-coding RNAs that form the catalytic core of the spliceosome complex and mediate the excision of introns from pre-mRNA[1][3]. However, RNU6-442P represents an inactive, nonfunctional copy of a U6 snRNA gene marked by accumulated mutations that prevent normal transcription or protein coding capability[2][5]. Unlike canonical U6 snRNAs, which are highly conserved and play a direct role in mRNA splicing in the nucleus, the RNU6-442P pseudogene has no documented biological function or disease association and is typically ignored in therapeutic contexts[5]. While some pseudogenes can acquire regulatory functions as non-coding RNAs, there is currently no evidence or documentation of any such function for RNU6-442P[2]. If you require structured information or mapping, RNU6-442P should generally be omitted as a drug target or disease biomarker, and its inclusion as a molecular target is not consistent with best practices in pharmacology and genetics.

Other names
RNU6-442PRNA, U6 small nuclear 442, pseudogeneNo common alternative names
02

Mechanism of action

None (no drugs are known to act via this pseudogene—if transcribed, theoretical regulatory mechanisms would include RNA interference, antisense regulation, or ceRNA effects, but no evidence is available for RNU6-442P)

03

Biological functions

Other (pseudogenes generally do not have canonical biological functions; a minority may play regulatory roles as non-coding RNAs, but this is not documented for RNU6-442P in available databases)
04

Disease associations

Other (no documented disease association for RNU6-442P; in rare cases, pseudogene transcripts affect gene regulation and may be implicated in disease—mostly cancer—but evidence is generally lacking for this gene)
05

Safety considerations

None (as a non-functional gene, RNU6-442P poses no therapeutic or safety-related concerns)
06

Interacting drugs

None (no drugs interact with or target RNU6-442P, as it is not a expressed, functional molecule)
07

Biomarkers

None (RNU6-442P is not used as a biomarker for any clinical diagnosis, prognosis, or therapy selection)

Beyond the preview

Go deeper on RNA, U6 small nuclear 442, pseudogene (RNU6-442P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 442, pseudogene (RNU6-442P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call